Dr. Christine Moore is the Deputy Director for Science and Policy and currently Acting Director of FDA's Office of New Drug Quality Assessment. She started at the agency in 2004 as the Branch Chief of the newly created Manufacturing Science group. Christine has been actively involved in FDA's Quality by Design initiatives and was a member of the expert working group for ICH Q8(R). Prior to joining the FDA, she worked for 10 years in API process development and scale-up at Pfizer and Searle/Pharmacia. Her background is in chemical and biochemical engineering, with degrees from Northwestern University and Massachusetts Institute of Technology.